Manulife (Manufacturers Life Insurance)
ENTA icon

Manulife (Manufacturers Life Insurance)’s Enanta Pharmaceuticals ENTA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,966
Closed -$727K – 2991
2023
Q1 		$727K Hold
17,966
– – ﹤0.01% 1779
2022
Q4 		$839K Sell
17,966
-27
-0.2% -$1.23K ﹤0.01% 1698
2022
Q3 		$939K Buy
17,993
+2,767
+18% +$162K ﹤0.01% 1635
2022
Q2 		$717K Sell
15,226
-2,189
-13% -$119K ﹤0.01% 1808
2022
Q1 		$1.22M Buy
17,415
+7,595
+77% +$494K ﹤0.01% 1663
2021
Q4 		$733 Sell
9,820
-94
-0.9% -$7.38K ﹤0.01% 2023
2021
Q3 		$563K Sell
9,914
-1,287
-11% -$63.6K ﹤0.01% 2198
2021
Q2 		$493K Buy
11,201
+65
+0.6% +$3.18K ﹤0.01% 2445
2021
Q1 		$549K Sell
11,136
-490
-4% -$24.4K ﹤0.01% 2215
2020
Q4 		$489K Buy
11,626
+389
+3% +$17.1K ﹤0.01% 2207
2020
Q3 		$514K Sell
11,237
-216
-2% -$10.5K ﹤0.01% 1988
2020
Q2 		$562K Sell
11,453
-284
-2% -$14.7K ﹤0.01% 1902
2020
Q1 		$604K Buy
11,737
+1,347
+13% +$71.8K ﹤0.01% 1742
2019
Q4 		$642K Sell
10,390
-329
-3% -$20.4K ﹤0.01% 1907
2019
Q3 		$646K Sell
10,719
-96
-0.9% -$7.13K ﹤0.01% 1872
2019
Q2 		$913K Sell
10,815
-216
-2% -$19.4K ﹤0.01% 1698
2019
Q1 		$1.05M Buy
11,031
+848
+8% +$76.1K ﹤0.01% 1657
2018
Q4 		$721K Sell
10,183
-788
-7% -$60.4K ﹤0.01% 1756
2018
Q3 		$938K Sell
10,971
-1,489
-12% -$149K ﹤0.01% 1841
2018
Q2 		$1.44M Buy
12,460
+850
+7% +$84.8K ﹤0.01% 1644
2018
Q1 		$940K Sell
11,610
-415
-3% -$31.9K ﹤0.01% 1877
2017
Q4 		$706K Buy
12,025
+51
+0.4% +$2.55K ﹤0.01% 2085
2017
Q3 		$560K Sell
11,974
-454
-4% -$18.2K ﹤0.01% 2200
2017
Q2 		$447K Sell
12,428
-81
-0.6% -$2.59K ﹤0.01% 2377
2017
Q1 		$385K Buy
12,509
+1,441
+13% +$44.9K ﹤0.01% 2369
2016
Q4 		$371K Sell
11,068
-36
-0.3% -$1.03K ﹤0.01% 2319
2016
Q3 		$295K Sell
11,104
-13
-0.1% -$302 ﹤0.01% 2461
2016
Q2 		$245K Buy
11,117
+386
+4% +$10.1K ﹤0.01% 2561
2016
Q1 		$306K Buy
10,731
+152
+1% +$4.23K ﹤0.01% 2297
2015
Q4 		$350 Buy
10,579
+104
+1% +$3.39K ﹤0.01% 2257
2015
Q3 		$379 Buy
10,475
+293
+3% +$12.6K ﹤0.01% 2186
2015
Q2 		$458 Buy
10,182
+3,046
+43% +$118K ﹤0.01% 2185
2015
Q1 		$218 Buy
7,136
+255
+4% +$9.92K ﹤0.01% 2669
2014
Q4 		$350 Sell
6,881
-171
-2% -$7.66K ﹤0.01% 2224
2014
Q3 		$279 Buy
7,052
+73
+1% +$2.91K ﹤0.01% 2396
2014
Q2 		$300K Buy
6,979
+3,667
+111% +$140K ﹤0.01% 2418
2014
Q1 		$133 Buy
3,312
+3,205
+2,995% +$116K ﹤0.01% 2952
2013
Q4 		$3 Buy
+107
New +$2.59K ﹤0.01% 3614
2013
Q3 		– Sell
-128
Closed -$2K – 3699
2013
Q2 		$2K Buy
+128
New +$2.5K ﹤0.01% 3401

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ENTA Position: Q2 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Enanta Pharmaceuticals (ENTA) in Q2 2023, closing a stake of 17,966 shares — an estimated $727K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ENTA in Q2 2013 and held it in 39 quarters. The position peaked at $1.44M in Q2 2018. 134 funds tracked by Wall St. Rank hold ENTA as of Q2 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Enanta Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 17,966 Enanta Pharmaceuticals shares in Q2 2023, an estimated $727K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Enanta Pharmaceuticals in Q2 2013 and held it in 39 quarters.
  • Manulife (Manufacturers Life Insurance)'s Enanta Pharmaceuticals position peaked at $1.44M in Q2 2018.
  • 134 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2023, filed 11 Aug 2023.